Prices delayed by at least 15 minutes | Print


Halozyme Therapeutics (HALO)

Common Shares
Sell: $38.86|Buy: $39.86|Change: 0.52 (1.32%)

This share can be held in a Dealing accountISALifetime ISAJISASIPP

Cash flow

Operating cash flow
Taxation
Investing activities
Financing
Foreign exchange adjustments
Opening balance